Early intermittent low-dose sclerostin antibody treatment promotes surface bone formation and reduces bone loss, but also decreases osteocyte apoptosis and mechanotransduction in ovariectomized rats: a pilot study
Sameer Naqvi, Wahaaj Ali, Hollie Allison, Laura O’Sullivan, Gill Holdsworth, Juan Alberto Panadero Pérez, Jessica Schiavi, Laoise M. McNamara
Bone Reports · Apr 7, 2026Peer-reviewedMolecular Biology